A5025221069- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Use and Resistance
- Pharmaceutical and Antibiotic Environmental Impacts
- Bacterial Identification and Susceptibility Testing
- Pneumonia and Respiratory Infections
- Lysosomal Storage Disorders Research
- Antimicrobial Resistance in Staphylococcus
- Mycobacterium research and diagnosis
- Enterobacteriaceae and Cronobacter Research
- Urinary Tract Infections Management
- Glycogen Storage Diseases and Myoclonus
- Carbohydrate Chemistry and Synthesis
- Trypanosoma species research and implications
- Streptococcal Infections and Treatments
- Child Nutrition and Feeding Issues
- Reproductive tract infections research
- Pharmaceutical studies and practices
- Medication Adherence and Compliance
- Cystic Fibrosis Research Advances
- Adsorption, diffusion, and thermodynamic properties of materials
- Phenothiazines and Benzothiazines Synthesis and Activities
- Personality Disorders and Psychopathology
- Poxvirus research and outbreaks
- Tracheal and airway disorders
Emory University
2024
University of Alabama at Birmingham
2024
Concordia University Wisconsin
2002-2024
Norfolk and Norwich University Hospitals NHS Foundation Trust
2021-2022
University of Pittsburgh
2022
Texas Tech University Health Sciences Center
2020
Texas Tech University
2020
International Diabetes Federation
2020
Scripps Research Institute
2011
Des Moines University
2006
ABSTRACT Between 1 September 2005 and 30 June 2006, 19 medical centers collected 4,180 isolates recovered from clinical specimens patients in intensive care units (ICUs) Canada. The were 2,292 respiratory (54.8%), 738 blood (17.7%), 581 wound/tissue (13.9%), 569 urinary (13.6%). 10 most common organisms isolated 79.5% of all methicillin-susceptible Staphylococcus aureus (MSSA) (16.4%), Escherichia coli (12.8%), Pseudomonas aeruginosa (10.0%), Haemophilus influenzae (7.9%), coagulase-negative...
ABSTRACT A total of 5,282 bacterial isolates obtained between 1 January and 31 December 2008, inclusive, from patients in 10 hospitals across Canada as part the Canadian Ward Surveillance Study (CANWARD 2008) underwent susceptibility testing. The most common organisms, representing 78.8% all clinical specimens, were follows: Escherichia coli (21.4%), methicillin-susceptible Staphylococcus aureus (MSSA; 13.9%), Streptococcus pneumoniae (10.3%), Pseudomonas aeruginosa (7.1%), Klebsiella...
Patients with Fabry disease (FD) are at a high risk for developing chronic kidney and cardiovascular disease. The availability of specific but costly therapy has elevated the profile this rare condition. This KDIGO conference addressed controversial areas in diagnosis, screening, management FD, included enzyme replacement nonspecific standard-of-care various manifestations FD. Despite marked advances patient care improved overall outlook, there is need to better understand pathogenesis...
The PRoposing Early Disease Indicators for Clinical Tracking in Fabry (PREDICT-FD) initiative aimed to reach consensus among a panel of global experts on early indicators disease progression that may justify FD-specific treatment initiation.Anonymous feedback from panellists via online questionnaires was analysed using modified Delphi technique. Questionnaires and data were managed by an independent administrator directed two non-voting cochairs. First, possible renal, cardiac...
To determine whether maternal antenatal therapy with vitamin K and phenobarbital prevents intracranial hemorrhage in premature newborns. Women at high risk for spontaneous or indicated delivery before 34 weeks' gestation were randomly assigned to receive either placebo phenobarbital. All patients received betamethasone antibiotics managed uniformly by a single perinatal group one hospital. newborns the same nursery neonatal group. Two independent interpretations of head ultrasound...
Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of α-galactosidase A. Symptoms include neuropathic pain and gastrointestinal problems, such as diarrhoea. To inform support the design Phase III clinical trial for new oral treatment disease, this study evaluated patients' experiences symptoms, impact symptoms on their quality life, views participating in trials.An online survey questionnaire was distributed to patients with through relevant patient organisations....
ABSTRACT From 1997 to 1999, 94 study centers in 15 European, 3 North American, and 2 South American countries contributed 2,632 isolates of Streptococcus pneumoniae an international antimicrobial susceptibility testing study. Only 62.0% were susceptible penicillin, while 22.3% penicillin intermediate 15.6% resistant. Resistance trimethoprim-sulfamethoxazole (24.4%), azithromycin (26.0%), clarithromycin (27.1%) was also highly prevalent. For the penicillin-resistant ( n = 411), MICs at which...
The clinical onset of Fabry disease, a rare, X-linked, multisystemic disorder, is marked by neuropathic pain. Males suffer extensively from this disease. Females, as genetic 'carriers', have traditionally been viewed either asymptomatic or mildly afflicted with disease.To describe Fabry-related pain and compare experiences between the sexes. Patients' perceptions physician assessments were also examined.A disease-specific questionnaire was accessible on-line (www.fabry.org) mailed to 552...
Abstract Background Fabry disease (FD) is a rare X-linked lysosomal storage disorder with heterogeneous clinical presentation. Patients FD may exhibit early signs/symptoms including neuropathic pain, gastrointestinal complaints, and dermatologic manifestations. ultimately progress to renal, neurologic, cardiac dysfunction. Current treatments for have significantly improved the management outcomes patients FD, but important convenience limitations still exist. Methods To illuminate impact of...
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTDetermination of Penicillin G in OJ. L. Johnson, W. A. Struck, E. J. Scott, and StaffordCite this: Anal. Chem. 1953, 25, 10, 1490–1492Publication Date (Print):October 1, 1953Publication History Published online1 May 2002Published inissue 1 October 1953https://pubs.acs.org/doi/10.1021/ac60082a021https://doi.org/10.1021/ac60082a021research-articleACS PublicationsRequest reuse permissionsArticle Views76Altmetric-Citations4LEARN ABOUT THESE...
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTMeasurement and Use of Substrate Partition Liquid Selectivities in Gas Chromatography.E. D. Smith J. L. JohnsonCite this: Anal. Chem. 1963, 35, 9, 1204–1207Publication Date (Print):August 1, 1963Publication History Published online1 May 2002Published inissue 1 August 1963https://doi.org/10.1021/ac60202a066RIGHTS & PERMISSIONSArticle Views13Altmetric-Citations8LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum full text article...